Does EVEROLIMUS Cause Hypertriglyceridaemia? 115 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Hypertriglyceridaemia have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.3% of all adverse event reports for EVEROLIMUS.
115
Reports of Hypertriglyceridaemia with EVEROLIMUS
0.3%
of all EVEROLIMUS reports
13
Deaths
42
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From EVEROLIMUS?
Of the 115 reports, 13 (11.3%) resulted in death, 42 (36.5%) required hospitalization, and 7 (6.1%) were considered life-threatening.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)
Which EVEROLIMUS Alternatives Have Lower Hypertriglyceridaemia Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE